The nation of Zimbabwe has declined a significant American health deal valued at $367m (£272m) spanning five years because of Washington's demand for sensitive data.
This rejection came to light following a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesman later clarified that the United States was requesting genetic material for research and commercial purposes but refused to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged further talks to secure a deal acceptable to both sides so the country's critical HIV programme can continue.
Broader Context
This rejection follows a comparable situation in Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of Kenyans' medical information.
After resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance openness and responsibility.
Based on statements, Sixteen African countries have so far signed these new agreements, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our citizens should a future health crisis arise."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting systems previously established via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage future global health emergencies.
"This mechanism is designed to guarantee that when a country provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
These objections over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future collaboration might be designed in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body said it recognised the official position, but recommended that talks must proceed considering much of the country's Aids initiatives relied on foreign aid.
"Where specific concerns exist, including those involving information security or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," it commented.
The halted deal underscores the continuing debate between receiving much-needed foreign assistance and protecting national sovereignty in an increasingly interconnected world.